Phase II Open Label Trial Galeterone Alone or Galeterone Combined With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Standard Chemotherapy (1911GCCC)
The purpose of this phase II trial is to assess the safety and effectiveness of galeterone with or without gemcitabine in patients with advanced pancreatic adenocarcinoma.
Study ID: 1911GCCC
Trial Phase: Phase II
Trial Sponsor: University of Maryland
Therapies Used in This Trial: Gemcitabine, Galeterone